Globular chitosan treatment of bovine jugular veins: evidence of anticalcification efficacy in the subcutaneous rat model

Kurobe, 2012, Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future, Stem Cells Transl Med, 1, 566, 10.5966/sctm.2012-0044 Torikai, 2008, A self-renewing, tissue-engineered vascular graft for arterial reconstruction, J Thorac Cardiovasc Surg, 136, 37, 10.1016/j.jtcvs.2007.06.039 Song, 2011, Tissue engineering of small-diameter vascular grafts: a literature review, Clin Hemorheol Microcirc, 49, 357, 10.3233/CH-2011-1486 Teebken, 2002, Tissue engineering of small diameter vascular grafts, Eur J Vasc Endovasc Surg, 23, 475, 10.1053/ejvs.2002.1654 Melchiorri, 2016, 3D-Printed biodegradable polymeric vascular grafts, Adv Healthc Mater, 5, 319, 10.1002/adhm.201500725 Lukyanov, 2014, Immediate postoperative results and long term outcome after Ross procedure among the pediatric population, Patol, Circ Pathol Cardiac Surg, 18, 5, 10.21688/1681-3472-2014-2-5-9 Brown, 2006, Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft, Ann Thorac Surg, 82, 909, 10.1016/j.athoracsur.2006.03.008 Sierra, 2007, Right ventricular outflow tract reconstruction: what conduit to use? Homograft or Contegra?, Ann Thorac Surg, 84, 606, 10.1016/j.athoracsur.2007.03.055 Hopkins, 2006, Bioprosthetic valves and laudable inflammation?, Circulation, 114, 261, 10.1161/CIRCULATIONAHA.106.639005 Carrel, 2004, Bovine valved jugular vein (Contegra) to reconstruct the right ventricular outflow tract, Expert Rev Med Devices, 1, 11, 10.1586/17434440.1.1.11 Appel, 2001, The pig as a source of cardiac xenografts, J Card Surg, 16, 345, 10.1111/j.1540-8191.2001.tb00534.x Golomb, 1987, The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses, Am J Pathol, 127, 122 Manji, 2006, Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection, Circulation, 114, 318, 10.1161/CIRCULATIONAHA.105.549311 Simionescu, 2004, Prevention of calcification in bioprosthetic heart valves: challenges and perspectives, Expert Opin Biol Ther, 4, 1971, 10.1517/14712598.4.12.1971 Ogle, 2003, Calcification resistance with aluminum–ethanol treated porcine aortic valve bioprostheses in juvenile sheep, Ann Thorac Surg, 75, 1267, 10.1016/S0003-4975(02)04489-2 Chen, 1994, Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves, Circulation, 90, 323, 10.1161/01.CIR.90.1.323 Vyavahare, 1997, Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms, Circulation, 95, 479, 10.1161/01.CIR.95.2.479 Campelo, 2017, Sulfonated chitosan and dopamine based coatings for metallic implants in contact with blood, Mater Sci Eng C, 72, 682, 10.1016/j.msec.2016.11.133 Clark, 2005, Prevention of calcification of bioprosthetic heart valve cusp and aortic wall with ethanol and aluminum chloride, Ann Thorac Surg, 79, 897, 10.1016/j.athoracsur.2004.08.084 Park, 1997, Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly(ethylene oxide), Biomaterials, 18, 47, 10.1016/S0142-9612(96)00096-8 Oosthuysen, 2006, Bioprosthetic tissue preservation by filling with a poly(acrylamide) hydrogel, Biomaterials, 27, 2123, 10.1016/j.biomaterials.2005.10.008 Ohri, 2004, Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium, J Biomed Mater Res A, 70, 328, 10.1002/jbm.a.30088 Rapoport, 2007, Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate, Biomaterials, 28, 690, 10.1016/j.biomaterials.2006.09.029 Moore, 1998, Evaluation of porcine valves prepared by dye-mediated photooxidation, Ann Thorac Surg, 66, S245, 10.1016/S0003-4975(98)01118-7 Park, 2013, The anti-calcification effect of dithiobispropionimidate, carbodiimide and ultraviolet irradiation cross-linking compared to glutaraldehyde in rabbit implantation models, Korean J Thorac Cardiovasc Surg, 46, 1, 10.5090/kjtcs.2013.46.1.1 Gallyamov, 2014, Collagen tissue treated with chitosan solutions in carbonic acid for improved biological prosthetic heart valves, Mater Sci Eng C, 37, 127, 10.1016/j.msec.2014.01.017 Polak, 2013, Inhibition of calcification of bovine pericardium after treatment with biopolymers, E-beam irradiation and in vitro endothelization, Mater Sci Eng C, 33, 85, 10.1016/j.msec.2012.08.009 Hopkins, 2009, Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep, J Thorac Cardiovasc Surg, 137, 907, 10.1016/j.jtcvs.2008.12.009 Steinhoff, 2000, Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits, Circulation, 102, III50, 10.1161/01.CIR.102.suppl_3.III-50 Wilson, 1995, Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement, Ann Thorac Surg, 60, S353, 10.1016/0003-4975(95)98967-Y Lichtenberg, 2006, In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions, Biomaterials, 27, 4221, 10.1016/j.biomaterials.2006.03.047 Vasilyeva, 2012, Morphofunctional assessment of fermentative and detergent methods of heart valve allografts decellularisation, Patol, Circ Pathol Cardiac Surg, 16, 77 Manji, 2015, Xenograft bioprosthetic heart valves: past, present and future, Int J Surg, 23, 280, 10.1016/j.ijsu.2015.07.009 Yuan, 2008, Right ventricular outflow tract reconstruction: valved conduit of choice and clinical outcomes, J Cardiovasc Med (Hagerstown), 9, 327, 10.2459/JCM.0b013e32821626ce Christenson, 2010, Homografts and xenografts for right ventricular outflow tract reconstruction: long-term results, Ann Thorac Surg, 90, 1287, 10.1016/j.athoracsur.2010.06.078 Falchetti, 2016, Contegra 12 mm: how long can it last?, World J Pediatr Congenit Heart Surg, 10.1177/2150135116675171 Flameng, 2011, Calcification of allograft and stentless xenograft valves for right ventricular outflow tract reconstruction: an experimental study in adolescent sheep, J Thorac Cardiovasc Surg, 141, 1513, 10.1016/j.jtcvs.2010.08.082 Nogueira, 2010, Bovine pericardium coated with biopolymeric films as an alternative to prevent calcification: in vitro calcification and cytotoxicity results, Mater Sci Eng C, 30, 575, 10.1016/j.msec.2010.02.011 Lima, 2013, Blood protein adsorption on sulfonated chitosan and κ-carrageenan films, Colloids Surf B Biointerfaces, 111, 719, 10.1016/j.colsurfb.2013.06.002 Fukunishi, 2016, Tissue-engineered small diameter arterial vascular grafts from cell-free nanofiber PCL/chitosan scaffolds in a sheep model, PLoS One, 11, 1, 10.1371/journal.pone.0158555 Kim, 2008, Chitosan and its derivatives for tissue engineering applications, Biotechnol Adv, 26, 1, 10.1016/j.biotechadv.2007.07.009 Kato, 2003, Application of chitin and chitosan derivatives in the pharmaceutical field, Curr Pharm Biotechnol, 4, 303, 10.2174/1389201033489748 Yuan, 2012, The Contegra valved bovine conduit: a biomaterial for the surgical treatment of congenital heart defects, Arq Bras Cardiol, 99, 1159, 10.1590/S0066-782X2012005000105 Siddiqui, 2012, Contegra valved conduit in the paediatric population: an exciting prospect for right ventricle to pulmonary artery reconstruction; experience and outcomes at Aga Khan University, J Pak Med Assoc, 62, 1113 Brown, 2011, Contegra versus pulmonary homografts for right ventricular outflow tract reconstruction: a ten-year single-institution comparison, World J Pediatr Congenit Heart Surg, 2, 541, 10.1177/2150135111415711 Pettenazzo, 2008, Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model, Eur J Cardiothorac Surg, 34, 418, 10.1016/j.ejcts.2008.05.012 Chanda, 1994, Posttreatment with amino compounds effective in prevention of calcification of glutaraldehyde treated pericardium, Artif Organs, 18, 408, 10.1111/j.1525-1594.1994.tb02223.x Shen, 2001, Effect of ethanol and ether in the prevention of calcification of bioprostheses, Ann Thorac Surg, 71, S413, 10.1016/S0003-4975(01)02521-8 Zilla, 2005, Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification, J Heart Valve Dis, 14, 538 Levy, 1983, Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats, Am J Pathol, 113, 143 Hosaka, 2009, Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells, Calcif Tissue Int, 85, 523, 10.1007/s00223-009-9297-8 Vyavahare, 1999, Elastin calcification and its prevention with aluminum chloride pretreatment, Am J Pathol, 155, 973, 10.1016/S0002-9440(10)65197-8 Schoen, 1999, Tissue heart valves: current challenges and future research perspectives, J Biomed Mater Res, 47, 439, 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O Barralet, 2002, Effect of elastin on the calcification rate of collagen–elastin matrix systems, J Biomed Mater Res, 60, 368, 10.1002/jbm.10077 Perrotta, 2011, New evidence for a critical role of elastin in calcification of native heart valves: Immunohistochemical and ultrastructural study with literature review, Histopathology, 59, 504, 10.1111/j.1365-2559.2011.03977.x Human, 2001, Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration?, J Long Term Eff Med Implants, 11, 199, 10.1615/JLongTermEffMedImplants.v11.i34.80 Mosch, 2017, Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus, Histol Histopathol, 293 Demer, 2014, Inflammatory, metabolic, and genetic mechanisms of vascular calcification, Arterioscler Thromb Vasc Biol, 34, 715, 10.1161/ATVBAHA.113.302070 Benesch, 2002, Blood protein adsorption onto chitosan, Biomaterials, 23, 2561, 10.1016/S0142-9612(01)00391-X Marchand, 2010, C3, C5, and factor B bind to chitosan without complement activation, J Biomed Mater Res A, 93, 1429